Cordova Ashley 4
4 · NovoCure Ltd · Filed Mar 3, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Cordova Ashley
Former Chief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-02-28$18.28/sh−2,341$42,804→ 206,058 total - Sale
Ordinary Shares
2025-02-27$20.55/sh−1,808$37,153→ 208,399 total - Sale
Ordinary Shares
2025-02-27$19.92/sh−9,345$186,170→ 210,207 total
Footnotes (3)
- [F1]On February 27, 2025, the reporting person sold 9,345 shares in multiple trades at prices ranging from $19.41 to $20.4033. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]On February 27, 2025, the reporting person sold 1,808 shares in multiple trades at prices ranging from $20.41 to $20.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]On February 28, 2025, the reporting person sold 2,341 shares in multiple trades at prices ranging from $18.175 to $18.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.